Published:
Sigma-Aldrich (Nasdaq: SIAL) CAO & CFO Hogan Plans to Retire; Search for Successor Underway
Sigma-Aldrich (Nasdaq: SIAL) CAO & CFO Hogan Plans to Retire; Search for Successor Underway
ST. LOUIS, May 14 /PRNewswire-FirstCall/ -- Sigma-Aldrich
(Nasdaq: SIAL) announced today that Chief Administrative Officer and Chief
Financial Officer Michael R. Hogan will retire at a date to be determined
this summer. Hogan, who turned 55 in April, had notified the Company
early this year of his desire to retire as soon as his successor could be
identified and successfully transitioned. The Company has initiated a
search to identify a successor from a pool of internal and external
candidates.
Following his retirement, Hogan will continue to assist with the
Company's charitable giving activities as an unpaid Vice President and
outside Director of the independent Sigma-Aldrich Foundation, which he
co-founded with Chairman David R. Harvey in 2004.
"From the day I joined Sigma-Aldrich, I've been very open about my
dream to devote full-time energy to volunteer civic and charitable work
after reaching early retirement age," Hogan said. "Sigma-Aldrich's
tremendous success over the past nine years has empowered me to pursue
that dream. I look forward to rooting from the sidelines as one of the
Company's biggest fans."
Company Chairman David Harvey said, "We express our sincere thanks and
gratitude to Mike for his dedication, professionalism, and his untiring
efforts on behalf of Sigma-Aldrich."
"Sigma-Aldrich is losing a valuable member of our executive team,"
said President & CEO Jai Nagarkatti. "But I am happy for Mike that he'll
be able to spend more of his time on the many charitable endeavors for
which he is known. Though we fully appreciate his decision to step back
from active management, we'll miss his strategic leadership, good judgment
and sense of humor."
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High
Technology company. Its biochemical and organic chemical products and kits
are used in scientific and genomic research, biotechnology, pharmaceutical
development, the diagnosis of disease and as key components in
pharmaceutical and other high technology manufacturing. The Company has
customers in life science companies, university and government
institutions, hospitals, and in industry. Over one million scientists and
technologists use its products. Sigma-Aldrich operates in 36 countries and
has 7,900 employees providing excellent service worldwide. Sigma-Aldrich
is committed to Accelerating Customer Success through Leadership in Life
Science, High Technology and Service. For more information about
Sigma-Aldrich, please visit its award-winning Web site at
http://www.sigma-aldrich.com.
SOURCE Sigma-Aldrich
Copyright © 2008, PRNewswire
Copyright © 2008, NewsBlaze,
Daily News
Tags: Healthcare, Pharmaceuticals, Biotechnology, Health, , missouri
_ _Is your favorite bookmark site missing?
Ask for it.